Article Figures & Data
Figures
- Figure 1
Contributors to elevated CMR
CMR—cardiometabolic risk, CRP—C-reactive protein, FFA—free fatty acid, HDL—high-density lipoprotein, IL-6—interleukin-6, LDL—low-density lipoprotein, Na—sodium, PAI-1—plasminogen activator inhibitor 1, TG—triglycerides, TNF—tumour necrosis factor. Data from Després and Lemieux.3
- Figure 2
Assessment and quantification of CMR
AHA—American Heart Association, BP—blood pressure, CMR—cardiometabolic risk, CV—cardiovascular, CVD—cardiovascular disease, DBP—diastolic blood pressure, DM—diabetes mellitus, FPG—fasting plasma glucose, HDL-C—high-density lipoprotein cholesterol, IDF—International Diabetes Federation, SBP—systolic blood pressure, TG—triglycerides.
- Figure 3
Pharmacologic interventions to reduce CMR
BP—blood pressure, CDA—Canadian Diabetes Association, CHEP—Canadian Hypertension Education Program, CKD—chronic kidney disease, CMR—cardiometabolic risk, CPG—clinical practice guidelines, CRP—C-reactive protein, DM—diabetes mellitus, HbA1c—hemoglobin A1c, LDL-C—low-density lipoprotein cholesterol.
In this issue
